Physician

Patrick Leung Tsui, D.O.

According to 2025 Medicare claims, Patrick Tsui, D.O. (NPI: 1598949166) practices family practice in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Catoosa, GA. This provider's primary affiliated billing organization is RINGGOLD MEDICAL CENTER (NPI: 1942279385; TIN: 58-2041471) and primary practice location at 30736-2367. Tsui is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Tsui's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 101 traditional Medicare patients, billed 36,482 HCPCS/CPT codes, and received $50,198 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,360 prescription claims across 205 beneficiaries totaling $620,706 in drug costs, led by Ozempic (Semaglutide). DME data shows 61 claims. Open Payments data shows 11 records totaling $236. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $348,217 to $620,706. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,179 and ending at $5,002.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	106	18,805	$50,003
2016	115	26,443	$46,591
2017	117	28,500	$47,396
2018	139	31,628	$52,493
2019	145	40,251	$61,284
2020	131	14,917	$47,109
2021	132	2,799	$59,788
2022	125	38,463	$56,759
2023	117	39,811	$56,078
2024	101	36,482	$50,198

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	3,725	$348,217
2016	151	3,982	$355,846
2017	161	4,172	$355,446
2018	180	4,620	$476,485
2019	207	4,432	$582,289
2020	217	4,323	$584,008
2021	214	3,923	$622,357
2022	210	4,178	$645,764
2023	226	4,081	$615,567
2024	205	4,360	$620,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	256	$21,064
2016	15	143	$14,548
2017	14	132	$11,225
2018	N/R	172	$13,784
2019	11	175	$13,752
2020	12	179	$13,732
2021	N/R	165	$5,344
2022	N/R	100	$3,008
2023	N/R	120	$4,192
2024	N/R	61	$2,218

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	57	57	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	89	350	$80
96372	Injection of drug or substance under skin or into muscle	56	563	$9
36415	Insertion of needle into vein for collection of blood sample	45	77	$9
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	38	66	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	85	3,478	$108,471
Farxiga	Dapagliflozin Propanediol	58	3,420	$63,821
Tresiba Flextouch U-200	Insulin Degludec	11	912	$41,148
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	40	1,500	$31,660
Eliquis	Apixaban	28	1,540	$30,224

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,247
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	14	$448
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	18	$274
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	11	$250

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$236	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Patrick Leung Tsui, D.O.?

Tedicare shows public-source Medicare data for Patrick Leung Tsui, D.O. (NPI 1598949166), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patrick Leung Tsui, D.O. have ACO affiliation data?

Patrick Leung Tsui, D.O. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Patrick Leung Tsui, D.O.?

Patrick Leung Tsui, D.O. is linked to RINGGOLD MEDICAL CENTER (billing NPI 1942279385) in the available physician profile data.

Does Patrick Leung Tsui, D.O. have Open Payments data?

Patrick Leung Tsui, D.O. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.